Australia - English - Department of Health (Therapeutic Goods Administration)

ikaria australia pty ltd - nitric oxide, quantity: 0.08 % w/w - gas, medicinal - excipient ingredients: nitrogen - inomax?, in conjunction with ventilatory support and other appropriate agents, is indicated -,- for the treatment of term and near-term ( greater than 34 weeks) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension, in order to improve oxygenation and to reduce the need for extracorporeal membrane oxygenation.,- to selectively decrease pulmonary arterial pressure in patients with perioperative pulmonary hypertension in conjunction with heart surgery

Australia - English - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - nitric oxide, quantity: 0.0004 mol - gas, medicinal - excipient ingredients: nitrogen - vasokinox is indicated in conjunction with ventilator support and other appropriate active substances to selectively decrease pulmonary arterial pressure in patients with perioperative pulmonary hypertension in conjunction with heart surgery

United States - English - NLM (National Library of Medicine)

ino therapeutics llc - nitric oxide (unii: 31c4ky9esh) (nitric oxide - unii:31c4ky9esh) - nitric oxide 0.98 mg in 1 l - inomax® is indicated to improve oxygenation and reduce the need for extracorporeal membrane oxygenation in term and near-term (>34 weeks gestation) neonates with hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in conjunction with ventilatory support and other appropriate agents. inomax is contraindicated in neonates dependent on right-to-left shunting of blood. the safety and efficacy of nitric oxide for inhalation has been demonstrated in term and near-term neonates with hypoxic respiratory failure associated with evidence of pulmonary hypertension [see clinical studies (14.1)]. additional studies conducted in premature neonates for the prevention of bronchopulmonary dysplasia have not demonstrated substantial evidence of efficacy [see clinical studies (14.3)]. no information about its effectiveness in other age populations is available. nitric oxide is not indicated for use in the adult population.

Australia - English - Department of Health (Therapeutic Goods Administration)

boc limited - nitric oxide, quantity: 1000 microlitre/l - gas, medicinal - excipient ingredients: nitrogen - pulmonary vasodilator

Australia - English - Department of Health (Therapeutic Goods Administration)

getinge australia pty ltd - 46319 - nitric oxide delivery system, secondary - the nitric oxide delivery and monitoring system delivers physician prescribed nitric oxide therapy gas to patients ranging from neonates to adults and monitors inspired no, no2 and o2 gas.

Canada - English - Health Canada

ino therapeutics - nitric oxide - gas - 100ppm - nitric oxide 100ppm - nitrates and nitrites

Canada - English - Health Canada

ino therapeutics - nitric oxide - gas - 800ppm - nitric oxide 800ppm - nitrates and nitrites

Canada - English - Health Canada

airgas therapeutics llc - nitric oxide - gas - 100ppm - nitric oxide 100ppm - nitrates and nitrites

Canada - English - Health Canada

airgas therapeutics llc - nitric oxide - gas - 800ppm - nitric oxide 800ppm - nitrates and nitrites

Canada - English - Health Canada

praxair canada inc - nitric oxide - gas - 100ppm - nitric oxide 100ppm - nitrates and nitrites